A Phase I Study of a Recombinant Chimeric Protein Composed of Circularly Permuted IL-4 and a Mutated Form of the Pseudomonas Exotoxin Termed IL-4(38-37)-PE38KDEL (IL-4 Toxin) for the Treatment of Recurrent Malignant Astrocytoma
Phase of Trial: Phase I
Latest Information Update: 24 Sep 2005
At a glance
- Drugs MDNA 55 (Primary)
- Indications Astrocytoma; Glioblastoma
- Focus Adverse reactions
- 24 Sep 2005 New trial record.